Compare 10X Genomics Inc (TXG) vs State Street Real Estate Select Sector SPDR ETF (XLRE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
10X Genomics Inc vs State Street Real Estate Select Sector SPDR ETF — how do they compare? 10X Genomics Inc trades at $46.82 (market cap $5.48B), while State Street Real Estate Select Sector SPDR ETF trades at $45.21. Which is the better fit depends on your goals.
| TXG | XLRE | |
|---|---|---|
Market Cap | $5.48B | — |
Sector | Health | Sector/Thematic |
52-Week High | $45.80 | $45.46 |
52-Week Low | $11.34 | $40.01 |
Enterprise Value | $5.02B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About 10X Genomics Inc
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →About State Street Real Estate Select Sector SPDR ETF
XLRE tracks the Real Estate Select Sector Index, providing exposure to S&P 500 real estate companies. It focuses on equity REITs across residential, industrial, and healthcare sub-sectors, with top holdings like Welltower, Prologis, and American Tower.
Read more on XLRE →
